Big day! 1st of 72 recruits injected in Phase I trial of Entos’ COVID-19 DNA vaccine, Covigenix VAX-001 at @VACCres. DNA vaccines deliver info to our cells to make viral protein to trigger immunity. @GPAinsights@UofAResearch @IWKHealth @DalhousieU@aegislifeinc#COVID19Vaccine
“We know that at least 30% of men will progress to worse tumours while we’re watching them,” said project lead Adam Kinnaird. “Is there a way from the get-go that you can determine if his cancer is more likely to progress and require treatment?” #UAlberta https://t.co/K5iW3MCvDz
Thank you @ABInnovates for your support to develop personalized DNA vaccines to treat cancer patients using the Fusogenix platform, lead by @UAlberta_FoMD John Lewis, with @entospharma, @APCaRI_CA, @AmiiThinks, & Cross Cancer oncologist Dr. Kolinsky.
https://t.co/YLNIfbLcQ4
Thanks to Nuzhat Tam-Saman @sinoveda & John Lewis @entospharma who provided a great synopsis on vaccine development. He reiterated need for a "made-in Canada" solution to COVID19 and need for up front & substantial invest can provide security for Canadians!
#imYEG is an industry-led, academic-based accelerator to address the earliest barriers researchers face on the #commercialization journey. Co-developed by @UAlberta & @BrassDomeV #CDNpse#ABleg https://t.co/m13yK8CoNV
Did you catch this piece from @edmontonjournal on Friday?
Read more on @entospharma's partnership with API and what it means for Canada's effort to produce a COVID-19 vaccine.
https://t.co/xbq3niKqoA
PR: Entos is developing a Fusogenix-DNA vaccine against COVID-19. Our Fusogenix platform will let us generate robust protection against SARS-COV-2. https://t.co/4EXKWZdFtv @Yeghealthcity @Bioalberta@UofAResearch @TECEdmonton https://t.co/o0rHFcPRWd
We’re at AIMSS today in Katz building UofA. CTO Rob Paproski gave a talk. Come by the booth to chat about how we use machine learning in our diagnostic platform ClarityDX. #ArtificialIntelligence#diagnostics#ProstateCancer